Screener
TransMedics Group, Inc. TMDX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by TransMedics Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206453
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Provision for income taxes | (1,170) | (994) |
| Net income | $7,315 | $25,682 |
| Net income per share: | ||
| Basic | $0.21 | $0.76 |
| Diluted | $0.20 | $0.70 |
| Weighted average common shares outstanding: | ||
| Basic | 34,384,207 | 33,721,603 |
| Diluted | 36,194,023 | 39,914,487 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is TransMedics Group, Inc.'s EPS (diluted)?
- TransMedics Group, Inc. (TMDX) reported EPS (diluted) of $0.20 in Q1 2026.
- How has TransMedics Group, Inc.'s EPS (diluted) changed year-over-year?
- TransMedics Group, Inc.'s EPS (diluted) decreased by 71.4% year-over-year, from $0.70 to $0.20.
- What is the long-term trend for TransMedics Group, Inc.'s EPS (diluted)?
- Over 3 years (2021 to 2025), TransMedics Group, Inc.'s EPS (diluted) has grown at a 44.6% compound annual growth rate (CAGR), from -$1.61 to $4.87.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about TransMedics Group, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude